{"id":101969,"date":"2026-03-19T12:59:19","date_gmt":"2026-03-19T10:59:19","guid":{"rendered":"https:\/\/www.ipsen.com\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/"},"modified":"2026-03-19T13:05:27","modified_gmt":"2026-03-19T11:05:27","slug":"etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante","status":"publish","type":"lay_language","link":"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/","title":{"rendered":"\u00c9tude visant \u00e0 \u00e9valuer la s\u00e9curit\u00e9 d\u2019emploi du ritivixibat chez des adultes atteints de cholangite scl\u00e9rosante"},"content":{"rendered":"\n<p>ritivixibat  <\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":11,"template":"","lay_language_category":[140082],"class_list":["post-101969","lay_language","type-lay_language","status-publish","has-post-thumbnail","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u00c9tude visant \u00e0 \u00e9valuer la s\u00e9curit\u00e9 d\u2019emploi du ritivixibat chez des adultes atteints de cholangite scl\u00e9rosante - Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9tude visant \u00e0 \u00e9valuer la s\u00e9curit\u00e9 d\u2019emploi du ritivixibat chez des adultes atteints de cholangite scl\u00e9rosante - Global\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T11:05:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2025\/04\/72x72-Lay-Summaries-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1949\" \/>\n\t<meta property=\"og:image:height\" content=\"1118\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/\",\"url\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/\",\"name\":\"\u00c9tude visant \u00e0 \u00e9valuer la s\u00e9curit\u00e9 d\u2019emploi du ritivixibat chez des adultes atteints de cholangite scl\u00e9rosante - Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2025\/04\/72x72-Lay-Summaries-1.png\",\"datePublished\":\"2026-03-19T10:59:19+00:00\",\"dateModified\":\"2026-03-19T11:05:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/#primaryimage\",\"url\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2025\/04\/72x72-Lay-Summaries-1.png\",\"contentUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2025\/04\/72x72-Lay-Summaries-1.png\",\"width\":1949,\"height\":1118},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c9tude visant \u00e0 \u00e9valuer la s\u00e9curit\u00e9 d\u2019emploi du ritivixibat chez des adultes atteints de cholangite scl\u00e9rosante\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c9tude visant \u00e0 \u00e9valuer la s\u00e9curit\u00e9 d\u2019emploi du ritivixibat chez des adultes atteints de cholangite scl\u00e9rosante - Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/","og_locale":"fr_FR","og_type":"article","og_title":"\u00c9tude visant \u00e0 \u00e9valuer la s\u00e9curit\u00e9 d\u2019emploi du ritivixibat chez des adultes atteints de cholangite scl\u00e9rosante - Global","og_url":"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/","og_site_name":"Global","article_modified_time":"2026-03-19T11:05:27+00:00","og_image":[{"width":1949,"height":1118,"url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2025\/04\/72x72-Lay-Summaries-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/","url":"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/","name":"\u00c9tude visant \u00e0 \u00e9valuer la s\u00e9curit\u00e9 d\u2019emploi du ritivixibat chez des adultes atteints de cholangite scl\u00e9rosante - Global","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2025\/04\/72x72-Lay-Summaries-1.png","datePublished":"2026-03-19T10:59:19+00:00","dateModified":"2026-03-19T11:05:27+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/#primaryimage","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2025\/04\/72x72-Lay-Summaries-1.png","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2025\/04\/72x72-Lay-Summaries-1.png","width":1949,"height":1118},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/etude-visant-a-evaluer-la-securite-demploi-du-ritivixibat-chez-des-adultes-atteints-de-cholangite-sclerosante\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"\u00c9tude visant \u00e0 \u00e9valuer la s\u00e9curit\u00e9 d\u2019emploi du ritivixibat chez des adultes atteints de cholangite scl\u00e9rosante"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language\/101969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/lay_language"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/11"}],"version-history":[{"count":1,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language\/101969\/revisions"}],"predecessor-version":[{"id":101970,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language\/101969\/revisions\/101970"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media\/78933"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=101969"}],"wp:term":[{"taxonomy":"lay_language_category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language_category?post=101969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}